About Index Trending news
Analyze
Pricing
Pluristem

Pluristem

Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

25 Oct 2016
$30,000,000
Post-IPO equity
Innovative Medical Management
17 Jun 2015
$2,900,000
Grant
Added by

Pluristem Therapeutics Inc. - June 17, 2015 (2)

pluristem